# Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression

> **NCT04936126** · PHASE4 · UNKNOWN · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 150 (estimated)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Quetiapine
- **DRUG:** Amantadine
- **DRUG:** Pramipexole

## Key facts

- **NCT ID:** NCT04936126
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-07
- **Primary completion:** 2024-07-07
- **Final completion:** 2024-09-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04936126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04936126, "Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04936126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*